Bosó V - Search Results

1

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies.

Rojas L, Neumann I, Herrero MJ, Bosó V, Reig J, Poveda JL, Megías J, Bea S, Aliño SF. Rojas L, et al. Among authors: boso v. Pharmacogenomics J. 2015 Feb;15(1):38-48. doi: 10.1038/tpj.2014.38. Epub 2014 Sep 9. Pharmacogenomics J. 2015. PMID: 25201288 Review.

2

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies.

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2015 Apr;15(2):109-18. doi: 10.1038/tpj.2014.80. Epub 2015 Jan 6. Pharmacogenomics J. 2015. PMID: 25558979

3

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis.

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2016 Feb;16(1):1-2. doi: 10.1038/tpj.2015.79. Epub 2015 Oct 27. Pharmacogenomics J. 2016. PMID: 26503809 Review. No abstract available.

4

A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.

Megías-Vericat JE, Herrero MJ, Rojas L, Montesinos P, Bosó V, Moscardó F, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2016 Feb;16(1):30-40. doi: 10.1038/tpj.2015.80. Epub 2015 Dec 8. Pharmacogenomics J. 2016. PMID: 26644203 Review.

5

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Rodríguez-Veiga R, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Megías-Vericat JE, et al. Among authors: boso v. Pharmacogenomics J. 2018 Apr;18(2):301-307. doi: 10.1038/tpj.2017.19. Epub 2017 May 9. Pharmacogenomics J. 2018. PMID: 28485375 Clinical Trial.

6

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF. Rojas LE, et al. Among authors: boso v. Pharmacogenet Genomics. 2013 Oct;23(10):509-17. doi: 10.1097/FPC.0b013e3283642fb3. Pharmacogenet Genomics. 2013. PMID: 23873120 Review.

7

SNPs and taxane toxicity in breast cancer patients.

Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF. Bosó V, et al. Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127. Pharmacogenomics. 2014. PMID: 25495407

8

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.

Sánchez-Lázaro I, Herrero MJ, Jordán-De Luna C, Bosó V, Almenar L, Rojas L, Martínez-Dolz L, Megías-Vericat JE, Sendra L, Miguel A, Poveda JL, Aliño SF. Sánchez-Lázaro I, et al. Among authors: boso v. Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24. Pharmacogenomics. 2015. PMID: 26107754

9

Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.

Bosó V, Herrero MJ, Bea S, Galiana M, Marrero P, Marqués MR, Hernández J, Sánchez-Plumed J, Poveda JL, Aliño SF. Bosó V, et al. Drug Metab Dispos. 2013 Feb;41(2):480-7. doi: 10.1124/dmd.112.047977. Epub 2012 Nov 21. Drug Metab Dispos. 2013. PMID: 23175667

10

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF. Bosó V, et al. Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65. Ther Drug Monit. 2014. PMID: 24232128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page